Momelotinib: Impact on transfusion dependence and QoL in MF

Описание: This educational resource is independently supported by GSK. All content is developed by SES in collaboration with an expert steering committee; funders are allowed no influence on the content of this resource.

Jean-Jacques Kiladjian, Professor of Clinical Pharmacology at Université Paris Cité, Paris, France, discusses the impact of momelotinib on transfusion dependence and QoL in MF. He reviews key data from the phase III SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM studies and the implications of these findings for treatment algorithms in patients with MF.